Yuyu

Yuyu Pharma to attend 'CPHI Worldwide 2023'

Retrieved on: 
Wednesday, October 18, 2023
Dutasteride, Yuyu, Nightclub

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.

Key Points: 
  • SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.
  • The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.
  • In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug.
  • These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia
    Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth.

Yuyu Pharma to attend 'CPHI Worldwide 2023'

Retrieved on: 
Wednesday, October 18, 2023
Dutasteride, Yuyu, Nightclub

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.

Key Points: 
  • SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.
  • The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.
  • In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug.
  • These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia
    Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth.

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®

Retrieved on: 
Tuesday, August 3, 2021
Health sciences, Drugs, Health care, Yuyu, Carbamazepine, Novartis, Tablet

"With their marketing capabilities and a strong compliance system, we believe Yuyu Pharma is the ideal partner.

Key Points: 
  • "With their marketing capabilities and a strong compliance system, we believe Yuyu Pharma is the ideal partner.
  • Wonsang Yu, CEO of Yuyu Pharma said, "We at Yuyu emphasize the importance of good business practices and compliance.
  • We thank Novartis Korea for entrusting us with these important products and will continue to meet the needs our customers and patients."
  • The Tegretol series consists of Tegretol slow-release film coated tablets, Tegretol tablets, and Tegretol syrup.

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®

Retrieved on: 
Tuesday, August 3, 2021
Health sciences, Drugs, Health care, Yuyu, Carbamazepine, Novartis, Tablet

"With their marketing capabilities and a strong compliance system, we believe Yuyu Pharma is the ideal partner.

Key Points: 
  • "With their marketing capabilities and a strong compliance system, we believe Yuyu Pharma is the ideal partner.
  • Wonsang Yu, CEO of Yuyu Pharma said, "We at Yuyu emphasize the importance of good business practices and compliance.
  • We thank Novartis Korea for entrusting us with these important products and will continue to meet the needs our customers and patients."
  • The Tegretol series consists of Tegretol slow-release film coated tablets, Tegretol tablets, and Tegretol syrup.

Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.

Retrieved on: 
Friday, May 28, 2021
Life sciences, Pharmaceutical industry, Biotechnology, Pharmaceuticals policy, Pharma, Yuyu, YU, Specialty drugs in the United States, Generic drug

During his 46-year term running Yuyu Pharma, Dr. Yu transformed Yuyu's product portfolio from one focusing on generic drugs to one focusing on specialty drugs.

Key Points: 
  • During his 46-year term running Yuyu Pharma, Dr. Yu transformed Yuyu's product portfolio from one focusing on generic drugs to one focusing on specialty drugs.
  • In anticipation of an aging society, Dr. Yu oversaw the introduction of two new improved drugs: Maxmarvil, for the treatment of osteoporosis and Yuclid, an antiplatelet drug.
  • In recognition of his efforts to improve public health as Chairman of the KPBA, Dr. Yu was awarded the Order of Merit in 2003.
  • After retirement, Dr. Yu will serve as honorary Chairman to Yuyu Pharma, continue to promote the culture and arts at Heyri Village, and continue to mentor young students at universities.

Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.

Retrieved on: 
Friday, May 28, 2021
Life sciences, Pharmaceutical industry, Biotechnology, Pharmaceuticals policy, Pharma, Yuyu, YU, Specialty drugs in the United States, Generic drug

During his 46-year term running Yuyu Pharma, Dr. Yu transformed Yuyu's product portfolio from one focusing on generic drugs to one focusing on specialty drugs.

Key Points: 
  • During his 46-year term running Yuyu Pharma, Dr. Yu transformed Yuyu's product portfolio from one focusing on generic drugs to one focusing on specialty drugs.
  • In anticipation of an aging society, Dr. Yu oversaw the introduction of two new improved drugs: Maxmarvil, for the treatment of osteoporosis and Yuclid, an antiplatelet drug.
  • In recognition of his efforts to improve public health as Chairman of the KPBA, Dr. Yu was awarded the Order of Merit in 2003.
  • After retirement, Dr. Yu will serve as honorary Chairman to Yuyu Pharma, continue to promote the culture and arts at Heyri Village, and continue to mentor young students at universities.

Yuyu Pharma was recognized as "Family-Friendly Company" by the Ministry of Gender Equality and Family

Retrieved on: 
Wednesday, December 30, 2020
Yuyu, YU, Ministry of Gender Equality and Family

SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ --Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) received recognition from the Ministry of Gender Equality and Family for implementing family-friendly policies for their employees.

Key Points: 
  • SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ --Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) received recognition from the Ministry of Gender Equality and Family for implementing family-friendly policies for their employees.
  • This is the second-time Yuyu has received this certification from the Ministry, as it was recognized as an "Outstanding Family-Friendly Company" back in 2015.
  • Yuyu Pharma has focused on initiating policies that make it possible for employees to balance family and work, and to improve the welfare of its employees.
  • Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

Yuyu Pharma was recognized as "Family-Friendly Company" by the Ministry of Gender Equality and Family

Retrieved on: 
Wednesday, December 30, 2020
Yuyu, YU, Ministry of Gender Equality and Family

SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ --Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) received recognition from the Ministry of Gender Equality and Family for implementing family-friendly policies for their employees.

Key Points: 
  • SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ --Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) received recognition from the Ministry of Gender Equality and Family for implementing family-friendly policies for their employees.
  • This is the second-time Yuyu has received this certification from the Ministry, as it was recognized as an "Outstanding Family-Friendly Company" back in 2015.
  • Yuyu Pharma has focused on initiating policies that make it possible for employees to balance family and work, and to improve the welfare of its employees.
  • Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

Retrieved on: 
Friday, September 4, 2020
Articles, Yuyu, Gender equality

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment.

Key Points: 
  • SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment.
  • The award was given at the 2020 Gender Equality Award Ceremony held on the 31st at the Government's Seong Convention Center.
  • "Eugene and our predecessors who have worked at Yuyu Pharma during its 80 year history laid the foundation for gender equality employment practices," said Robert Yu, CEO of Yuyu Pharma.
  • Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

Retrieved on: 
Friday, September 4, 2020
Articles, Yuyu, Gender equality

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment.

Key Points: 
  • SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment.
  • The award was given at the 2020 Gender Equality Award Ceremony held on the 31st at the Government's Seong Convention Center.
  • "Eugene and our predecessors who have worked at Yuyu Pharma during its 80 year history laid the foundation for gender equality employment practices," said Robert Yu, CEO of Yuyu Pharma.
  • Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.